Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Twenty-Eight Week, Open-Label, Safety Study of Flibanserin 50 Mgs to 100 Mgs Daily in Premenopausal European Women With HSDD
Brief Summary: Safety profile of flibanserin over 28 additional weeks Distribution of preferred dose regimens